Delivery formulations

G1 Therapeutics: trilaciclib shows benefits for lung cancer patients

14-May-2020 By Jenni Spinner

The company will present data from recent Phase 2 trials of the investigational drug at the upcoming ASCO20 virtual conference on May 29.

3M Drug Delivery Systems relaunches as Kindeva Drug Delivery

04-May-2020 By Jenni Spinner

The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners.

Saama launches COVID-19 data collaboration

06-Apr-2020 By Jenni Spinner

The company’s EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus.

FDA approves migraine drug formulated for fast dispersion

19-Mar-2020 By Vassia Barba

Biohaven’s drug for acute treatment of migraine, manufactured using Catalent’s Zydis technology for orally disintegrating tablets, receives approval from the US FDA.

Formulation method improves bioavailability of poorly soluble molecules

09-Mar-2020 By Vassia Barba

Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.

Merck KGaA partners on 3D-printed tablets manufacture

27-Feb-2020 By Vassia Barba

Merck to produce 3D-printed tablets by tapping into the technology developed by AMCM, making a move towards digitalization.

Taro recalls seizure medicine over suspension problems

24-Feb-2020 By Ben Hargreaves

Taro instigates a voluntary recall of phenytoin oral suspension after two lots are found not to re-suspend when shaken.

Formulation technology improving CBD uptake bought out

20-Feb-2020 By Vassia Barba

Bioavailability of water insoluble compounds, such as CBD, enhanced up to 15 times with the technology of Solmic, leading to its acquisition by Betterlife.

Branded generics forecast to double revenues, with US and Europe left behind

12-Feb-2020 By Vassia Barba

Global sales of branded generic drugs are expected to progress at 8% CAGR through 2029, but the US and Europe are not set to drive this growth.

US FDA finds fault with standards at Aurobindo's oral solids facility

03-Feb-2020 By Nick Taylor

Aurobindo Pharma reveals US FDA found objectionable conditions at its oral solids manufacturing facility.

FDA unanimously shuts down Nektar’s opioid painkiller

16-Jan-2020 By Ben Hargreaves

The US FDA’s advisory committee voted 27-0 against recommending approval of oxycodegol, with Nektar deciding to withdraw its application as a result.

Hikma, Arecor partner on Arestat formulation technology

13-Jan-2020 By Vassia Barba

Hikma taps Arestat, a formulation technology for protein- and peptide-based drugs, to develop an injectable medicine, ahead of filing for US FDA approval.

Catalent to formulate CBD multiple sclerosis treatment with Zydis

16-Dec-2019 By Vassia Barba

Catalent enters partnership with Ethicann on Zydis technology to formulate CBD and THC combination treatment for muscular spasticity.

Celltrion gets EMA nod for subcutaneous infliximab biosimilar

28-Nov-2019 By Vassia Barba

Celltrion receives EMA marketing authorisation for Remsima SC, the first subcutaneously-administered option for delivery of infliximab, a treatment for rheumatoid arthritis.

Cycle taps into Catalent’s Zydis tech to manufacture four products

31-Oct-2019 By Vassia Barba

Cycle looks to benefit from the advantages of Zydis oral disintegrating tablet technology, developed by Catalent, for four of its drug products treating rare diseases.